They are classified as glucagon-like peptide 1 (GLP-1) agonists and, in addition to diabetes treatment, also demonstrate ...
The phase 3 trial success over Lilly’s Trulicity (dulaglutide), an already-marketed GLP-1 class rival, further bolsters semaglutide's profile ahead of its anticipated approval later this year as ...
Other drugs included first-generation GLP-1 drugs -- liraglutide (Victoza, Saxenda), and dulaglutide (Trulicity) -- as well as bupropion/naltrexone (Contrave) and metformin. Of note, dulaglutide ...
Another trial in patients with T2D and mean A1c of 7.6%, previously treated with diet alone or single oral agent, showed that once-weekly dosing of dulaglutide significantly reduced both fasting ...